Recently, a point mutation in the coagulation Factor V gene (G to A in
position 1691) has been identified which makes the mutant Factor V (c
alled Factor V Leiden) resistant to activated protein C. This defect i
s a well established genetic risk factor in venous thrombosis. Because
of the high prevalence of Factor V Leiden in normal population (2-7%)
, it would be reasonable to perform a rapid and simple method for scre
ening the genetic abnormality in population at risk. We have developed
a simple, reproducible, rapid and cheap procedure that, using PCR and
SSCP, allows the identification of the mutation responsible for Facto
r V Leiden. Specificity of this method has been tested in 319 samples:
304 normal, 14 heterozygous and 1 homozygous for Factor V Leiden. Thi
s assay allows non-isotopic Factor V Leiden identification by using fr
ozen whole blood in 3 h. All these features make this test adequate fo
r routine screening of this mutation in a large number of samples.